Latest Market Access News

The Supreme Court of New South Wales has approved schemes of arrangement that transfer Nova Minerals' ownership to a new US holding company, with ASX trading set to suspend immediately.

Magnum Mining has completed OTCIQ submissions to secure a U.S. OTCID listing, enhancing access for American investors as it accelerates exploration across its Brazilian and U.S. rare earth, gold, and copper projects.

1414 Degrees has formed an Aerospace, Drone & Defence Advisory Board featuring six veterans from top defence and aerospace firms to accelerate the rollout of its SiNTL silicon anode battery technology targeting drones and adjacent markets.

EcoGraf confirms its patented HFfree process offers competitive costs for producing high-purity spherical graphite, targeting non-Chinese battery supply chains with plans for facilities in the US, Europe, and Asia.

OncoSil Medical has secured a pivotal ethics committee approval in Italy, reclassifying its OSPRItaly registry and enabling a streamlined procurement process that could double the number of authorised hospitals using its OncoSil™ device by mid-2027.

CleanSpace Holdings expects modest revenue growth for FY26, hindered by product certification delays and global market challenges, while maintaining a strong cash position and preparing a new respirator launch.

Osteopore has secured Hainan FDA approval to clinically use and sell its custom orthopaedic devices at Shanghai Ruijin Hospital’s Hainan branch, marking a key step towards wider China market access. The company has scheduled its first patient surgery for June 2026.

Aroa Biosurgery posted a breakout FY26, beating revenue and EBITDA guidance with a 54% surge in Myriad sales. The company plans significant investments in FY27 to accelerate growth and capitalise on new market opportunities.

X2M Connect has secured a manufacturing licence for South Korea's first AI-enabled integrated smart water meter, aiming to capture a $1.3 billion hardware market and $52 million in recurring SaaS revenue by solving critical connectivity challenges.

Cleo Diagnostics has laid out a clear U.S. reimbursement pathway for its ovarian cancer test, leveraging an existing CPT code to enable early market entry and data collection ahead of FDA clearance.

American Tungsten & Antimony Ltd (ASX: AT4) has raised A$10 million through a strongly supported placement and secured a 40% Utah state tax credit, underpinning its strategy to develop a domestic US supply chain for tungsten and antimony ahead of a planned Nasdaq listing.

Provaris Energy, alongside Kawasaki Kisen Kaisha (K LINE) and Norwegian Hydrogen, has formalised a cooperation to develop a commercial hydrogen shipping supply chain from Norway to Northern Europe, focusing on cost modelling and charter terms for compressed hydrogen transport.